Hi Mozz,
Regarding what you have written, placebo is constant - it doesn't change from trial to trial. It can't. It has no therapeutic effect.
So how is it that the placebo effect in our trial was more than double that of the tanezumab trial? Do you have a theory on that?At week 8, the proportion of patients with at least a 50% improvement in average pain was 12.3% in the placebo arm and 25.4% in the tanezumab arm (P=.0405).1
How do we compare?
55% of participants receiving iPPS twice weekly reported >50% improvement in pain
compared to 28% in the placebo arm.2
Ann: Paradigm Board Changes, page-41
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 387930 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 65468 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |